Figure 10.
(A) Principal linker L in position C(6) of benzoxaboroles; (B) Structures and antitrypanosomal activity of no boron analogues 101–103; (C) Structures, antitrypanosomal activity, cytotoxicity and biological half-life t1/2 of benzoxaborole derivatives S-series 104–106 and N-series 107–109 (Adapted from [94]).